Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
BioNumerik Pharmaceuticals revenue
BioNumerik Pharmaceuticals's revenue is $4.5 million.
What is BioNumerik Pharmaceuticals's revenue?
- BioNumerik Pharmaceuticals has 50 employees, and the revenue per employee ratio is $90,000.
- BioNumerik Pharmaceuticals peak revenue was $4.5M in 2024.
On this page
Zippi applies for you, and finds you a job.
BioNumerik Pharmaceuticals financing
BioNumerik Pharmaceuticals received early financing of $52.0M on 2004-10-08.
| Series | Round size | Date |
|---|---|---|
| Corporate Round | $52M | 10/2004 |
| Series Unknown | $1.1M | 11/2010 |
| Series Unknown | $10.2M | 11/2012 |
BioNumerik Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Takeda | Corporate Round |
BioNumerik Pharmaceuticals competitors
BioNumerik Pharmaceuticals's top competitor, Amylin Pharmaceuticals, earned an annual revenue of $650.7M.
BioNumerik Pharmaceuticals's smallest competitor is Product Safety Engineering with revenue of $370.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Ariad Pharmaceuticals | - | $118.8M | 380 | - |
| Amylin Pharmaceuticals | - | $650.7M | 1,300 | - |
| Technology Assesment & Transfer | - | $1.5M | 15 | - |
| OPX | - | $4.3M | 46 | - |
| Product Safety Engineering | - | $370,000 | 10 | - |
| Fluidigm | - | $174.4M | 535 | - |
| Cato Research | - | $28.9M | 200 | - |
| Ceramatec | - | $9.6M | 100 | - |
BioNumerik Pharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
BioNumerik Pharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of BioNumerik Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about BioNumerik Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at BioNumerik Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by BioNumerik Pharmaceuticals. The data presented on this page does not represent the view of BioNumerik Pharmaceuticals and its employees or that of Zippia.
BioNumerik Pharmaceuticals may also be known as or be related to BioNumerik Pharmaceuticals, BioNumerik Pharmaceuticals Inc., BioNumerik Pharmaceuticals, Inc. and Bionumerik Pharmaceuticals, Inc.